| Name | Title | Contact Details |
|---|
Octane Lending is a point of sales finance and insurance marketplace that helps salesmen help their customer`s obtain financing. We are currently focused on the recreational market (motorcycles, ATVs, UTVs, Personal watercrafts, boats, RVs and snowmobiles). Our web based platform helps dealers save time by eliminating the need to rekey customer information and helps move more units by opening dealerships to more prime/subprime lending sources. We leverage our large merchant network to act as an efficient compliment to lenders` existing loan origination systems.
LogMeIn simplifies the way people connect to each other and the world around them. We provide cloud-based collaboration, customer engagement, connected objects, and IT management offerings required to empower, manage, secure and support the mobile workplace. Our offerings include join.me, Xively, Central, AppGuru, Cubby, BoldChat, and Rescue. When everything`s connected, anything is possible. LogMeIn. Simply possible™. LogMeIn`s world headquarters are located in Boston, Massachusetts, with offices in Australia, Hungary, India, Ireland, and the UK.
Blytheco is one of the leading companies in Software and Internet industry. Blytheco is based in Laguna Hills, CA. You can find more information on Blytheco at www.blytheco.com
Exent Technologies is one of the leading companies in Software and Internet industry. Exent Technologies is based in New York, NY. You can find more information on Exent Technologies at www.exent.com
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.